Trian Investors 1 welcomes Anita Rival to its Board as Independent Director

– GUERNSEY, St Peter Port –  Trian Investors 1 Limited (LON: TI1) today announced the appointment of Anita Rival to its Board as an independent non-executive Director with effect from 14 April 2022.

“I am delighted to welcome Anita to the Board of Trian Investors 1 Limited. She brings a wealth of experience in the asset selection and risk assessment process and her fellow directors look forward to her involvement in the challenges and opportunities which lie ahead.” said Board Chairman, Chris Sherwell.

Anita Rival will also join each Board committee.

About Anita Rival

Ms. Rival is a trustee of Baron Investment Funds Trust and an independent director of Impala Asset Management. From April 2011 through May 2012, she served as an independent advisor to Magnetar Capital, a multi-strategy hedge fund. From 1999 until her retirement in February 2009, Ms. Rival was a Partner and Portfolio Manager at Harris Alternatives, LLC, and its predecessor, Harris Associates, L.P.

Ms. Rival brings expertise in capital markets, portfolio management, and business operations. As a Portfolio Manager at Harris Alternatives, LLC, she managed all aspects of a $14 billion fund of hedge funds, including asset selection, risk assessment and allocation across investment strategies. Before Harris Alternatives, LLC, Ms. Rival held senior-level positions at several large asset management/investment banking institutions, including Banker’s Trust, Global Asset Management, and Merrill Lynch Capital Markets. Ms. Rival received her B.A. in 1985 from Harvard University.

For more information: https://www.trianinvestors1.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.